Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, May 16, 2023.
On today’s episode, Fast Five Hosts Danielle Kirsh and Sean Whooley discuss new data from Biosense Webster’s radiofrequency ablation system. The study results suggest better treatment of atrial fibrillation using the company’s QDOT catheter. This breakthrough technology offers promising results for patients suffering from this common heart rhythm disorder, providing new possibilities for more effective treatment options.
BrainsWay has launched a study program aimed at evaluating the effectiveness of its deep transcranial magnetic stimulation (dTMS) technology. The technology is used to treat several neurological and psychiatric conditions, including depression, obsessive-compulsive disorder, and smoking cessation. Whooley gives an inside look at how the technology works and what the company hopes to achieve in the study.
Continuous glucose monitoring maker Dexcom has released new clinical evidence supporting the use of its G6 continuous glucose monitoring (CGM) system in Japan. The G6 CGM system is designed to help people with diabetes manage their glucose levels by providing real-time glucose readings, and the new data could be a big step for diabetes management in Japan. Fast Five hosts Kirsh and Whooley discuss the results of the study and what it means for people living with diabetes.
Onward Medical has completed the first-in-human use of its implantable lead device for restoring movement in people with spinal cord injuries. The initial results are promising, with patients demonstrating improved control and quality of life. Whooley details how the technology works and what more is to come from the company.
New reports are suggesting that medical device giants Medtronic and Johnson & Johnson are both considering acquiring Shockwave Medical. The acquisition would give both companies access to cutting-edge technology that has the potential to revolutionize the treatment of cardiovascular disease. Hosts Kirsh and Whooley give more insight into the speculated bids.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.
